At a recent clinical discussion, the message was clear: traditional pharmacologic pathways alone are not enough for many patients with IBD and IBS. Clinicians are increasingly exploring adjunct and alternative approaches—not as replacements, but as necessary complements to standard care.
For IBS in particular, the shift is more philosophical than therapeutic. The condition often lacks a clear structural cause, pushing clinicians toward open-minded, patient-centered care that integrates behavioral and functional strategies. Approaches like cognitive behavioral therapy, hypnotherapy, and stress-focused interventions are gaining traction—not because they are “alternative,” but because they address the gut–brain axis that drugs alone cannot fully target.